ZOETIS INC (ZTS) Stock Price, Quote, News and Overview
NYSE:ZTS - New York Stock Exchange, Inc. - US98978V1035 - Common Stock - Currency: USD
ZTS Quote, Performance and Key Statistics
ZOETIS INC
NYSE:ZTS (2/4/2025, 8:17:47 PM)
After market: 172.24 0 (0%)172.24
+0.3 (+0.17%)
The current stock price of ZTS is 172.24 USD. In the past month the price increased by 5.47%. In the past year, price decreased by -12.71%.
ZTS Latest News, Press Releases and Analysis
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever
These companies lead their respective markets, making them must-haves for buy-and-hold dividend investors.
Is Zoetis Inc. (NYSE: ZTS) Overvalued? Or Is It Worth Buying Now?
/PRNewswire/ -- Zoetis's recent report has investors wondering if the company's stock is overvalued. Or is it in the buy range? As such, the Editorial Advisory...
Zoetis to Host Webcast and Conference Call on Fourth Quarter and Full Year 2024 Financial Results
ZTS Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 81.23 | 784.20B | ||
| JNJ | JOHNSON & JOHNSON | 15.36 | 369.55B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 28.2 | 366.85B | ||
| MRK | MERCK & CO. INC. | 15.25 | 229.54B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 18.1 | 213.85B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 13.32 | 210.86B | ||
| PFE | PFIZER INC | 10.03 | 146.61B | ||
| SNY | SANOFI-ADR | 14.82 | 134.13B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 50.53 | 119.91B | ||
| GSK | GSK PLC-SPON ADR | 8.46 | 71.08B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 22.2 | 42.23B | ||
| TEVA | TEVA PHARMACEUTICAL-SP ADR | 6.85 | 19.33B |
Related stock screener links
About ZTS
Company Profile
Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. The company is headquartered in Parsippany, New Jersey and currently employs 14,100 full-time employees. The company went IPO on 2013-02-01. The firm is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health. The firm operates through two segments: the United States (U.S.) and International. Within each of these operating segments, it offers a diversified product portfolio, including parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics, for both companion animal and livestock customers. The company directly markets its products in approximately 45 countries across North America, Europe, Africa, Asia, Australia and South America. The company is engaged in commercializing products across eight core species: dogs, cats and horses (collectively, companion animals) and cattle, poultry, swine, fish and sheep (collectively, livestock).
Company Info
ZOETIS INC
10 Sylvan Way
Parsippany NEW JERSEY 07054 US
CEO: Kristin C. Peck
Employees: 14100
Company Website: https://www.zoetis.com/
Investor Relations: https://investor.zoetis.com
Phone: 19738227000
ZTS FAQ
What is the stock price of ZTS?
The current stock price of ZTS is 172.24 USD.
What is the symbol for ZOETIS INC stock?
The exchange symbol of ZOETIS INC is ZTS and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is ZTS stock listed?
ZTS stock is listed on the New York Stock Exchange, Inc. exchange.
Is ZTS a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for ZTS, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of ZTS.
Does ZTS stock pay dividends?
ZTS has a dividend yield of 1.16%. The yearly dividend amount is currently 1.5.
When does ZTS stock report earnings?
ZTS will report earnings on 2025-02-13, after the market close.
What is the Price/Earnings (PE) ratio of ZTS?
The PE ratio for ZTS is 29.9. This is based on the reported non-GAAP earnings per share of 5.76 and the current share price of 172.24 USD.
What is the Short Interest ratio of ZTS stock?
The outstanding short interest for ZTS is 1.58% of its float.
ZTS Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to ZTS. When comparing the yearly performance of all stocks, ZTS is a bad performer in the overall market: 75.44% of all stocks are doing better.
ZTS Fundamental Analysis
ChartMill assigns a fundamental rating of 7 / 10 to ZTS. ZTS gets an excellent profitability rating and is at the same time showing great financial health properties.
ZTS Financial Highlights
Over the last trailing twelve months ZTS reported a non-GAAP Earnings per Share(EPS) of 5.76. The EPS increased by 10.13% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 26.55% | ||
| ROA | 16.93% | ||
| ROE | 46.43% | ||
| Debt/Equity | 1.26 |
ZTS Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 82% to ZTS. The Buy consensus is the average rating of analysts ratings from 25 analysts.
For the next year, analysts expect an EPS growth of 11.74% and a revenue growth 8.51% for ZTS